Cargando…

Isobaric mass tagging and triple quadrupole mass spectrometry to determine lipid biomarker candidates for Alzheimer's disease

The isobaric tagging method widely used in proteomic and lipidomic fields, with the multiple reaction monitoring (MRM) approach using a triple quadrupole mass spectrometer, was applied to identify biomarker candidates from plasma samples for Alzheimer’s disease (AD). We focused on the following phos...

Descripción completa

Detalles Bibliográficos
Autores principales: Tokuoka, Suzumi M., Kita, Yoshihiro, Shimizu, Takao, Oda, Yoshiya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6903722/
https://www.ncbi.nlm.nih.gov/pubmed/31821352
http://dx.doi.org/10.1371/journal.pone.0226073
_version_ 1783477897504227328
author Tokuoka, Suzumi M.
Kita, Yoshihiro
Shimizu, Takao
Oda, Yoshiya
author_facet Tokuoka, Suzumi M.
Kita, Yoshihiro
Shimizu, Takao
Oda, Yoshiya
author_sort Tokuoka, Suzumi M.
collection PubMed
description The isobaric tagging method widely used in proteomic and lipidomic fields, with the multiple reaction monitoring (MRM) approach using a triple quadrupole mass spectrometer, was applied to identify biomarker candidates from plasma samples for Alzheimer’s disease (AD). We focused on the following phospholipids that have amino groups as the functional group: phosphatidylethanolamine (PE), Lyso-PE, phosphatidylserine, and Lyso-phosphatidylserine. We also investigated fatty acids that have a carboxy group. A sixplex tandem mass tag (TMT) was used for the isobaric tagging method in this study. The TMT reaction had high reproducibility in human plasma. A total of 196 human plasma samples from three AD cohorts were used for the study, and compared to pooled plasma quality control (QC) samples. The described method required only 40 MRM measurements, including the pooled QC samples, for a full comparison of the data. We found that the content of free fatty acids increased in AD samples in all the three cohorts, alkenyl PEs (ePEs) decreased over a one-year interval in AD patients, and ePEs weakly correlated with amyloid peptide (a-beta) 1–42 in cerebrospinal fluid. In conclusion, total free fatty acids in plasma are a risk factor for AD, and ePEs monitor candidates for AD. Therefore, TMT-lipidomics is a powerful approach for the determination of plasma biomarkers because of the high sample throughput.
format Online
Article
Text
id pubmed-6903722
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-69037222019-12-20 Isobaric mass tagging and triple quadrupole mass spectrometry to determine lipid biomarker candidates for Alzheimer's disease Tokuoka, Suzumi M. Kita, Yoshihiro Shimizu, Takao Oda, Yoshiya PLoS One Research Article The isobaric tagging method widely used in proteomic and lipidomic fields, with the multiple reaction monitoring (MRM) approach using a triple quadrupole mass spectrometer, was applied to identify biomarker candidates from plasma samples for Alzheimer’s disease (AD). We focused on the following phospholipids that have amino groups as the functional group: phosphatidylethanolamine (PE), Lyso-PE, phosphatidylserine, and Lyso-phosphatidylserine. We also investigated fatty acids that have a carboxy group. A sixplex tandem mass tag (TMT) was used for the isobaric tagging method in this study. The TMT reaction had high reproducibility in human plasma. A total of 196 human plasma samples from three AD cohorts were used for the study, and compared to pooled plasma quality control (QC) samples. The described method required only 40 MRM measurements, including the pooled QC samples, for a full comparison of the data. We found that the content of free fatty acids increased in AD samples in all the three cohorts, alkenyl PEs (ePEs) decreased over a one-year interval in AD patients, and ePEs weakly correlated with amyloid peptide (a-beta) 1–42 in cerebrospinal fluid. In conclusion, total free fatty acids in plasma are a risk factor for AD, and ePEs monitor candidates for AD. Therefore, TMT-lipidomics is a powerful approach for the determination of plasma biomarkers because of the high sample throughput. Public Library of Science 2019-12-10 /pmc/articles/PMC6903722/ /pubmed/31821352 http://dx.doi.org/10.1371/journal.pone.0226073 Text en © 2019 Tokuoka et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Tokuoka, Suzumi M.
Kita, Yoshihiro
Shimizu, Takao
Oda, Yoshiya
Isobaric mass tagging and triple quadrupole mass spectrometry to determine lipid biomarker candidates for Alzheimer's disease
title Isobaric mass tagging and triple quadrupole mass spectrometry to determine lipid biomarker candidates for Alzheimer's disease
title_full Isobaric mass tagging and triple quadrupole mass spectrometry to determine lipid biomarker candidates for Alzheimer's disease
title_fullStr Isobaric mass tagging and triple quadrupole mass spectrometry to determine lipid biomarker candidates for Alzheimer's disease
title_full_unstemmed Isobaric mass tagging and triple quadrupole mass spectrometry to determine lipid biomarker candidates for Alzheimer's disease
title_short Isobaric mass tagging and triple quadrupole mass spectrometry to determine lipid biomarker candidates for Alzheimer's disease
title_sort isobaric mass tagging and triple quadrupole mass spectrometry to determine lipid biomarker candidates for alzheimer's disease
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6903722/
https://www.ncbi.nlm.nih.gov/pubmed/31821352
http://dx.doi.org/10.1371/journal.pone.0226073
work_keys_str_mv AT tokuokasuzumim isobaricmasstaggingandtriplequadrupolemassspectrometrytodeterminelipidbiomarkercandidatesforalzheimersdisease
AT kitayoshihiro isobaricmasstaggingandtriplequadrupolemassspectrometrytodeterminelipidbiomarkercandidatesforalzheimersdisease
AT shimizutakao isobaricmasstaggingandtriplequadrupolemassspectrometrytodeterminelipidbiomarkercandidatesforalzheimersdisease
AT odayoshiya isobaricmasstaggingandtriplequadrupolemassspectrometrytodeterminelipidbiomarkercandidatesforalzheimersdisease